Cargando…
An added dimension to tumour TRAIL sensitivity
Autores principales: | Healy, Sandra, O'Leary, Lynda, Szegezdi, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675782/ https://www.ncbi.nlm.nih.gov/pubmed/26697519 |
Ejemplares similares
-
Kinetics in Signal Transduction Pathways Involving Promiscuous Oligomerizing Receptors Can Be Determined by Receptor Specificity: Apoptosis Induction by TRAIL
por: Szegezdi, Eva, et al.
Publicado: (2012) -
Co-acting gene networks predict TRAIL responsiveness of tumour cells with high accuracy
por: O’Reilly, Paul, et al.
Publicado: (2014) -
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
por: van Dijk, Marianne, et al.
Publicado: (2011) -
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
por: Alizadeh Zeinabad, Hojjat, et al.
Publicado: (2022) -
CASE – Adding a New Dimension to the Conversation
por: Stepien, Rebecca L.
Publicado: (2020)